Rchr
J-GLOBAL ID:201801011745301983
Update date: Nov. 01, 2024
Kobayashi Tetsu
コバヤシ テツ | Kobayashi Tetsu
Affiliation and department:
Job title:
professor
Research field (1):
Respiratory medicine
Research theme for competitive and other funds (10):
- 2022 - 2025 The role of the lung microbiota-derived proapoptotic peptide (corisin) in COPD
- 2021 - 2024 肺癌発症における細菌叢の関与の研究
- 2020 - 2023 MUC5B過剰発現マウスを用いた肺線維症の細菌叢異常におけるムチンの役割の検討
- 2018 - 2021 Evaluating the role of the lung microbiome in pulmonary fibrosis
- 2017 - 2020 Development of novel therapeutic approaches for pulmonary fibrosis using MUC5B overexpressing mice
- 2013 - 2016 RNAi for the treatment of refractory pulmonary diseases
- 2012 - 2015 Development of new therapeutic strategies for chronic obstructive diseases using RNA interference
- 2010 - 2012 siRNA for the treatment of airway remodeling
- 2009 - 2011 EVALUATING THE PATHOGENESIS AND DEVELOPMENT OF NOVEL THERAPIES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING GENE-ENGINEERED MICE
- 2007 - 2008 Epithelial mesenchymal transition during airway remodeling
Show all
Papers (169):
-
Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, Tomohito Okano, Taro Yasuma, Esteban C. Gabazza, Hidenori Ibata, Tetsu Kobayashi. Transforming Lung Cancer Management: A Promising Case Study of Immune Checkpoint Inhibitor Success Following a Multidisciplinary Approach. Diagnostics. 2024. 14. 19. 2159-2159
-
Suphachai Tharavecharak, Hajime Fujimoto, Taro Yasuma, Corina N. D’Alessandro-Gabazza, Masaaki Toda, Atsushi Tomaru, Haruko Saiki, Mei Uemura, Yurie Kogue, Toshiyuki Ito, et al. Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant. Cells. 2024. 13. 18. 1523-1523
-
Takuya Iwamoto, Hajime Fujimoto, Tetsu Kobayashi, Esteban C. Gabazza. Lymphocyte activation markers predict the therapeutic response to immune checkpoint inhibitors: A case-control study. Cancer Medicine. 2024. 13. 12
-
Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, Kentaro Ito, Atsushi Fujiwara, Hisamichi Yuda, Hidetoshi Itani, Masahiro Naito, Shuji Kodama, Kazuki Furuhashi, et al. Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors. Cancer Medicine. 2024. 13. 8
-
Tatsuki Tsuruga, Hajime Fujimoto, Taro Yasuma, Corina N D'Alessandro-Gabazza, Masaaki Toda, Toshiyuki Ito, Atsushi Tomaru, Haruko Saiki, Tomohito Okano, Manal A B Alhawsawi, et al. Role of Microbiota-Derived Corisin in Coagulation Activation during SARS-CoV-2 Infection. Journal of thrombosis and haemostasis : JTH. 2024
more...
MISC (33):
-
Kentaro Ito, Osamu Hataji, Yuta Suzuki, Haruko Saiki, Tadashi Sakaguchi, Kosuke Hayashi, Yoichi Nishii, Fumiaki Watanabe, Tetsu Kobayashi, Esteban Gabazza, et al. The Utility of Liquid-Biopsy for Detecting EGFR Mutation in Clinical Practice: 169 Cases in a Single Institution Research Study. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S542-S542
-
Tadashi Sakaguchi, Osamu Hataji, Yuta Suzuki, Haruko Saiki, Kentaro Ito, Yoichi Nishii, Kosuke Hayashi, Fumiaki Watanabe, Tetsu Kobayashi, Esteban Gabazza, et al. A Retrospective Study of the Efficacy and Safety of Nivolumab in Our Clinical Practice: A Single Institutional Experience. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S1340-S1340
-
Kentaro Ito, Hataji Osamu, Yuta Suzuki, Saiki Haruko, Tadashi Sakaguchi, Kosuke Hayashi, Yoichi Nishii, Fumiaki Watanabe, Atsushi Fijiwara, Masamichi Yoshida, et al. Comparative Analysis of the Efficacy of Three 1st/2nd Generation EGFR-TKIs for EGFR Mutated NSCLC in Clinical Practice. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S1226-S1226
-
J. Hinneh, C. N. D'Alessandro-Gabazza, M. Toda, T. Yasuma, F. Kentaro, K. Nishihama, T. Kobayashi, H. Etsuko, E. Gabazza, Y. Yazunori. Preclinical efficacy of Periostin short interfering RNA in pulmonary fibrosis. EUROPEAN JOURNAL OF IMMUNOLOGY. 2016. 46. 582-582
-
J. Hinneh, C. N. D'Alessandro-Gabazza, M. Toda, T. Yasuma, F. Kentaro, K. Nishihama, T. Kobayashi, H. Etsuko, E. Gabazza, Y. Yazunori. Preclinical efficacy of Periostin short interfering RNA in pulmonary fibrosis. EUROPEAN JOURNAL OF IMMUNOLOGY. 2016. 46. 1250-1250
more...
Education (1):
Professional career (1):
Work history (4):
- 2021/07 - 現在 三重大学大学院医学系研究科臨床医学系講座 呼吸器内科学分野/代謝内分泌内科学分野 教授
- 2006/01 - 現在 三重大学医学部附属病院呼吸器内科
- 2000/11 - 2005/11 米国ネブラスカメディカルセンター呼吸器内科部門
- 1991/03 - 三重大学医学部 卒業
Association Membership(s) (8):
欧州呼吸器学会(ERS)
, 米国胸部疾患学会(ATS)
, 日本臨床腫瘍学会
, 日本肺癌学会
, 日本アレルギー学会
, 日本呼吸器内視鏡学会
, 日本呼吸器学会
, 日本内科学会
Return to Previous Page